Double trouble in follicular lymphoma: A rare and unusual synergy of oncogenes in the germinal center

References

• Christie L, Kernohan N, Levison D, Sales M, Cunningham J, Gillespie K, Batstone P, et al. C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator?. Leuk Lymphoma 2008; 49: 470–476
   PubMed Web of Science ®Google Scholar
• Salles G A. Clinical features, prognosis and treatment of follicular lymphoma. Hematol Am Soc Hematol Educ Program 2007; 2007: 216–225
   Google Scholar
• Lin P, Medeiros L J. High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis. Haematologica 2007; 92: 1297–1301
   PubMed Web of Science ®Google Scholar
• Natkunam Y. The biology of the germinal center. Hematol Am Soc Hematol Educ Program 2007; 2007: 210–215
   Google Scholar
• Alizadeh A A, Eisen M B, Davis R E, Ma C, Lossos I S, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511
   PubMed Web of Science ®Google Scholar
• Huang J Z, Sanger W G, Greiner T C, Staudt L M, Weisenburger D D, Pickering D L, et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 2002; 99: 2285–2290
   PubMed Web of Science ®Google Scholar
• Iqbal J, Sanger W G, Horsman D E, Rosenwald A, Pickering D L, Dave B, et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol 2004; 165: 159–166
   PubMed Web of Science ®Google Scholar
• McDonnell T J, Korsmeyer S J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991; 349: 254–256
   PubMed Web of Science ®Google Scholar
• Evan G, Littlewood T. A matter of life and cell death. Science 1998; 281: 1317–1322
   PubMed Web of Science ®Google Scholar
• Strasser A, Harris A W, Bath M L, Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 1990; 348: 331–333
   PubMed Web of Science ®Google Scholar
• Yano T, Jaffe E S, Longo D L, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80: 758–767
   PubMed Web of Science ®Google Scholar
• Lossos I S, Alizadeh A A, Diehn M, Warnke R, Thorstenson Y, Oefner P J, et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci USA 2002; 99: 8886–8891
   PubMed Web of Science ®Google Scholar
• Martinez-Climent J A, Alizadeh A A, Segraves R, Blesa D, Rubio-Moscardo F, Albertson D G, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 2003; 101: 3109–3117
   PubMed Web of Science ®Google Scholar
• Egle A, Harris A W, Bath M L, O'Reilly L, Cory S. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 2004; 103: 2276–2283
   PubMed Web of Science ®Google Scholar
• Dave S S, Wright G, Tan B, Rosenwald A, Gascoyne R D, Chan W C, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159–2169
   PubMed Web of Science ®Google Scholar
• Wilson A, Murphy M J, Oskarsson T, Kaloulis K, Bettess M D, Oser G M, et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004; 18: 2747–2763
   PubMed Web of Science ®Google Scholar
• Letai A, Sorcinelli M D, Beard C, Korsmeyer S J. Antiapoptotic BCL-2 is required for maintenance of a model leukemia. Cancer Cell 2004; 6: 241–249
   PubMed Web of Science ®Google Scholar
• Kelly P N, Puthalakath H, Adams J M, Strasser A. Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma. Blood 2007; 109: 4907–4913
   PubMed Web of Science ®Google Scholar
• Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth T F, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419–2430
   PubMed Web of Science ®Google Scholar
• Le Gouill S, Talmant P, Touzeau C, Moreau A, Garand R, Juge-Morineau N, et al. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92: 1335–1342
   PubMed Web of Science ®Google Scholar
• Dave S S, Fu K, Wright G W, Lam L T, Kluin P, Boerma E J, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006; 354: 2431–2442
   PubMed Web of Science ®Google Scholar